Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The colonic wall is the layered structure forming the outer boundary of the colon, a major part of the large intestine. It comprises the mucosa, submucosa, muscularis propria, and serosa/subserosa. Its primary functions include absorption of water and electrolytes, mucus production for lubrication, and peristalsis to propel feces. The wall contains various cell types, including absorptive columnar cells, goblet cells, enteroendocrine cells, Paneth cells, and stem cells. It is a complex anatomical structure rather than a single molecular entity or receptor, and is affected by a variety of diseases and therapeutic interventions.
Varies depending on the drug. Anti-inflammatory drugs reduce inflammation, antibiotics target bacteria, chemotherapeutic agents target cancer cells, laxatives promote bowel movements, antidiarrheals slow down bowel movements.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonic Wall (None).